Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04529551 · ClinicalTrials.gov registry record · NA

CSD1601: A Study to Evaluate the Exposure to Tar and Nicotine From Two Cigarette Products That Contain a Menthol Capsule in the Filter

A NA study, sponsored by RAI Services Company.

Completed
Registry status
NA
Development phase
55
Enrollment target

NCT04529551 is a NA study that has completed, run by RAI Services Company. The registered enrollment target is 55 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04529551, a NA study, has completed, sponsored by RAI Services Company.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target

Study Summary

This study will evaluate exposure to tar and nicotine from two cigarette products that contain a menthol capsule in the filter, and provide a basis for comparing mouth-level exposure when smokers smoke the two cigarette products.

Interventions

  • OTHER 1601A
  • OTHER 1601B

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2016-04-08
Est. Completion 2016-05-02
Phase NA

Sponsor

RAI Services Company

42 total trials

What the Registry Record Tells You About NCT04529551

The ClinicalTrials.gov registry entry for NCT04529551 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which 1601A is the first listed.

NCT04529551 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04529551 about?

NCT04529551 is a clinical study titled "CSD1601: A Study to Evaluate the Exposure to Tar and Nicotine From Two Cigarette Products That Contain a Menthol Capsule in the Filter". This study will evaluate exposure to tar and nicotine from two cigarette products that contain a menthol capsule in the filter, and provide a basis for comparing mouth-level exposure when smokers smoke the two cigarette products.

What is the current status of trial NCT04529551?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2016-04-08. Estimated completion is 2016-05-02.

What interventions are being tested in trial NCT04529551?

The interventions under investigation include: 1601A (OTHER), 1601B (OTHER).

Who is sponsoring clinical trial NCT04529551?

This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.